Thoratec Corp.
Newfield Exploration Co.
Hawkins Inc.

Company Events for Alnylam Pharmaceuticals, Inc. (ALNY)

Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Daily Price Action:
Date Open High Low Close Volume
2010-03-2917.5017.5117.0317.17195400
2010-03-2617.9518.1117.2017.41180600
2010-03-2518.2418.4517.8917.93136000
2010-03-2418.7818.8518.0118.07206000
2010-03-2318.0518.7217.8018.70219200
2010-03-2217.6618.1417.5017.99158300
2010-03-1917.8917.9317.5817.68144500
2010-03-1817.9017.9317.6017.79104100
2010-03-1718.1718.2017.9117.92129600
2010-03-1618.2618.3718.0618.16181900
2010-03-1518.3118.3718.1118.1574500
2010-03-1218.6918.6918.1618.28118000
2010-03-1118.1818.7718.1818.7099800
2010-03-1018.2218.7418.1818.32145100
2010-03-0918.0618.4318.0618.1695200
2010-03-0818.2718.4418.0318.17153200
2010-03-0518.0518.4117.4818.24163700
2010-03-0417.9518.0317.5218.01151900
2010-03-0317.8118.3917.8117.89129300
2010-03-0217.5617.9017.4917.73148800
2010-03-0117.4617.8417.3217.48174300
2010-02-2617.9518.1217.2017.42218200
2010-02-2517.7217.9717.5517.97133400
2010-02-2417.8918.1817.7017.94157600
2010-02-2317.0317.9116.9617.79269100
2010-02-2217.4017.4716.9717.0185100
2010-02-1917.4317.4817.2417.39101500
2010-02-1817.4317.5317.2717.4351600
2010-02-1717.5017.5417.2317.49107400
2010-02-1617.5217.5917.2317.40100500
2010-02-1216.9517.4816.9517.48122400
2010-02-1116.7517.2416.6117.15128900
Recent Company Events:
24-Nov-09Alnylam Pharma downgraded by Roth Capital
4-Nov-09Alnylam Pharmaceuticals Earnings Call scheduled for 4:30 pm ET today
4-Nov-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a
25-Aug-09Price hit new 52-week high ($24.75)
21-Aug-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
7-Aug-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
6-Aug-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
27-Jul-09Price hit new 52-week high ($23.44)
17-Jul-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
2-Jul-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
8-May-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
7-May-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
5-May-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
9-Mar-09Price hit new 52-week low ($14.82)
4-Mar-09Price hit new 52-week low ($15.85)
3-Mar-09Price hit new 52-week low ($15.87)
2-Mar-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
24-Feb-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
6-Feb-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
15-Jan-09ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
15-Dec-08ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers

Other Companies:   WVS Financial Corp. | Par Pharmaceutical Companies Inc. | Winnebago Industries Inc.